1Por A Kaya,B Poyraz,G Celik,et al.Vascular Endothelial Growth Factor in Benign and Malignant Plcural Effusions[J].Arch Bronconeumol,2005,41 (7):376-379.
2Thickett DR,Armstrong L,Millar AB.Vascular endothelial growth factor(VEGF) in inflammatory and malignant pleural effusions[J].Thorax,1999,54(8):707 -710.
3Zebrowski BK,Yano S,Liu W,et al.Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions[J].Clin Cancer Res,1999,5(11):3364-3368.
4Zebrowski BK,Yano S,Liu W,et al.Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions[J].Clin CancerRes,1999,5(11):3 364-3 368.
5Ishimoto O,Saijo Y,Narumi K,et al.High level of vascular endothelial growth factor in hemorrhagic pleural effusion of cancer[J].Oncology,2002,63(1):70-75.
6Mohammed KA,Nasreen N,Hardwick J,et al.Mycobacteria induces pleural mesothelial permeability by down regulating betacatenin expression[J].Lung,2003,181(2):57-66.
7Qhta Y,Tanaka Y,Hara T,et al.Clinicopathological and biological assessment of lung cancer with pleural dissemination[J].Ann Thorac Surg,2000,69:1 025-1 029.
8Yano S,Herbst RS,Shinohars H,et al.Treatment for malignant pieural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phospherylation[J].Clin Cancer Res,2000,6(3):955-958.
